Mitchell Glass
Präsident bei MYMD PHARMACEUTICALS, INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christopher Schreiber | M | 58 | 7 Jahre | |
| Joshua Silverman | M | 54 | 6 Jahre | |
| Thian Chew | M | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics Pty Ltd. develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | 7 Jahre |
| Brendon Lau | M | - | - | |
| Jude Uzonwanne | M | 50 | 3 Jahre | |
| G. John Mohr | M | - |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Accolade Pharma LLC is a pharmaceutical company that specializes in developing topical formulations and devices for the active ingredient of Accolate® (zafirlukast) to treat allergic inflammation. The private company is based in Wilmington, DE. Leukotriene antagonists modify allergic responses by blocking leukotrienes, which prevents or decreases symptoms of acute inflammation such as wheezing, sneezing, itching, redness, and swelling. The company was founded in 2012 by G. John Mohr, who has been the CEO since 2012. | 12 Jahre |
| Michael DiPiano | M | 65 |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | 19 Jahre |
| Melanie Leydin | F | 51 | 4 Jahre | |
| Bill White | M | 63 | 7 Jahre | |
| Craig Eagle | M | 57 | 3 Jahre | |
| Craig R. Carnaroli | M | - |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | 19 Jahre |
| Jenna Brager | M | - | 3 Jahre | |
| Robert Schatz | M | - | - | |
| Vinod Vijayakumar | M | - |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics Pty Ltd. develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | - |
| Michael P. Silvon | M | 76 |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics Pty Ltd. develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | - |
| Rob Merriel | M | - | 4 Jahre | |
| Alan Yamashita | M | 74 | 5 Jahre | |
| Alistair Bennallack | M | - | 4 Jahre | |
| Claire Newstead-Sinclair | F | - | 3 Jahre | |
| Ian Rhodes | M | 51 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christopher Chapman | M | 71 | 4 Jahre | |
| Gregory Collier | M | - | 6 Jahre | |
| Charles Deignan | M | 59 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 Jahre |
| Craig Newton | M | - | 2 Jahre | |
| Todd Eugene Petzel | M | - |
The University of Chicago
| 7 Jahre |
| Geri Sands Hansen | F | - |
The University of Chicago
| 4 Jahre |
| James Brett Lochran Heading | M | 67 | 4 Jahre | |
| Sanford J. Grossman | M | - |
The University of Chicago
| 6 Jahre |
| Don N. Kleinmuntz | M | - |
The University of Chicago
| 8 Jahre |
| Richard Walter Grayston | M | 80 |
The University of Chicago
| 4 Jahre |
| Marc R. Reinganum | M | - |
The University of Chicago
| 5 Jahre |
| Kenneth L. Cutler | M | - |
The University of Chicago
| 4 Jahre |
| Mary Patricia Quinn | F | - |
The University of Chicago
| 5 Jahre |
| Brady Dougan | M | 64 |
The University of Chicago
| 5 Jahre |
| Sun Chi Chan | M | 73 |
The University of Chicago
| 4 Jahre |
| Ralph Craven | M | 73 | 4 Jahre | |
| Mauricio Antonio González Gómez | M | - |
The University of Chicago
| 3 Jahre |
| Cláudio Luiz da Silva Haddad | M | 77 |
The University of Chicago
| 4 Jahre |
| Warren Thomas Brown | M | - | 7 Jahre | |
| Mark P. Colonnese | M | 68 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 Jahre |
| Theo Vermaelen | M | 70 |
The University of Chicago
| 6 Jahre |
| Victor Canto | M | - |
The University of Chicago
| 5 Jahre |
| Manuel Iglesias | M | 69 |
The University of Chicago
| 6 Jahre |
| Garner William | M | 58 | 1 Jahre | |
| Bhanusak Asvaintra | M | 79 |
The University of Chicago
| 2 Jahre |
| Stu J. Sweet | M | - |
The University of Chicago
| 6 Jahre |
| George K. Hersh | M | - |
The University of Chicago
| 6 Jahre |
| Michael C. Markovitz | M | 70 |
The University of Chicago
| 3 Jahre |
| Jeffrey Skelton | M | 74 |
The University of Chicago
| 6 Jahre |
| Myron Samuel Scholes | M | 82 |
The University of Chicago
| 12 Jahre |
| Robert Scott | M | 70 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 Jahre |
| Easton Ragsdale | M | 73 |
The University of Chicago
| 8 Jahre |
| T. Eric Kilcollin | M | - |
The University of Chicago
| 5 Jahre |
| Michael Anthony Duffy | M | - |
The University of Chicago
| 8 Jahre |
| Charles Frederick Pohl | M | - |
The University of Chicago
| 5 Jahre |
| David Cotton | M | 71 |
The University of Chicago
| 4 Jahre |
| Ronald Horne | M | 79 |
The University of Chicago
| 4 Jahre |
| George Masek | M | - |
The University of Chicago
| 2 Jahre |
| Marcel Fournier | M | 69 |
The University of Chicago
| 2 Jahre |
| Herbert W. Krueger | M | - |
The University of Chicago
| 3 Jahre |
| Jay Cohen | M | - |
The University of Chicago
| 3 Jahre |
| Joe Jesson | M | - |
The University of Chicago
| 4 Jahre |
| Mitsuo Kitagawa | M | 77 |
The University of Chicago
| 1 Jahre |
| George N. Rifkin | M | - |
The University of Chicago
| 2 Jahre |
| Greg W. Renz | M | - |
The University of Chicago
| 3 Jahre |
| John F. Rosenthal | M | - |
The University of Chicago
| 3 Jahre |
| Gordon Hamilton | M | 68 |
The University of Chicago
| 4 Jahre |
| John Osth | M | 77 |
The University of Chicago
| 2 Jahre |
| John A. Salvette | M | 67 |
The University of Chicago
| 2 Jahre |
| David Eisenbud | M | - |
The University of Chicago
| 3 Jahre |
| Gary I. Singer | M | - |
The University of Chicago
| 2 Jahre |
| David L. Cotton | M | - |
The University of Chicago
| 1 Jahre |
| Thomas H. Hopkins | M | - |
The University of Chicago
| 4 Jahre |
| Brian Cartwright | M | 76 |
The University of Chicago
| 3 Jahre |
| John Baily | M | 80 |
The University of Chicago
| 2 Jahre |
| H. David Kavrell | M | - |
The University of Chicago
| 2 Jahre |
| Tibor D. Klopfer | M | - |
The University of Chicago
| 3 Jahre |
| Joe Rizzi | M | - |
The University of Chicago
| 2 Jahre |
| Jay Trees | M | - |
The University of Chicago
| 2 Jahre |
| Thomas Tedoff Kutzen | M | 71 |
The University of Chicago
| 2 Jahre |
| Robert F. Weber | M | - |
The University of Chicago
| 3 Jahre |
| Daniel Zaldivar | M | - |
The University of Chicago
| 4 Jahre |
| James W. Lewis | M | 82 |
The University of Chicago
| 2 Jahre |
| Tin Fan Yuen | M | 70 |
The University of Chicago
| 4 Jahre |
| Craig R. Dean | M | - |
The University of Chicago
| 4 Jahre |
| Nicholas Pritzker | M | 79 |
The University of Chicago
| 3 Jahre |
| Gregory S. Samorajski | M | - |
The University of Chicago
| 2 Jahre |
| Carlos Geraldo Langoni | M | 79 |
The University of Chicago
| 3 Jahre |
| David J. Steirman | M | - |
The University of Chicago
| 2 Jahre |
| Joan Marie Giardina | F | 75 |
The University of Chicago
| 2 Jahre |
| Thomas A. Cole | M | - |
The University of Chicago
| 4 Jahre |
| Stephen Timothy Kochis | M | - |
The University of Chicago
| 2 Jahre |
| John Prann | M | 73 |
The University of Chicago
| 2 Jahre |
| Steve Herman | M | 80 |
The University of Chicago
| 2 Jahre |
| Philip Arthur Epstein | M | 68 |
The University of Chicago
| 4 Jahre |
| Matthew Dominski | M | 69 |
The University of Chicago
| 2 Jahre |
| Dominic C. Yang | M | - |
The University of Chicago
| 4 Jahre |
| Adam de Sola Pool | M | - |
The University of Chicago
| 4 Jahre |
| Robert j. Minkus | M | - |
The University of Chicago
| 3 Jahre |
| Lawrence Kinet | M | 77 |
The University of Chicago
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 85 | 85,00% |
| Australien | 15 | 15,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mitchell Glass
- Persönliches Netzwerk
